BioDlink International (1875) Announces Update on Relevant Securities and Takeovers Code Disclosure

Bulletin Express

03/01

BioDlink International Company Limited (stock code: 1875) issued an update regarding its relevant securities pursuant to Rule 3.8 of the Hong Kong Code on Takeovers and Mergers. According to the announcement, 142,000 share options vested on 1 March 2026.

Following this vesting, the company has 772.79 million shares in issue. Among these, 30.02 million are outstanding vested RSA shares for which the full consideration has not yet been received, and 14.56 million remain unvested. In addition, 7.63 million share options remain outstanding, of which 7.35 million are vested but unexercised, and 0.14 million remain unvested.

The announcement reminds all associates of the company and the offeror—including holders of 5% or more of the relevant securities—to comply with rule-based disclosure obligations during the offer period. It further cautions that completion of the offers is subject to fulfillment or waiver of certain conditions and may therefore not become unconditional.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1136110878"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1136110878\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1136110878?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-01 18:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1136110878","market":"us","top_or_hot":-1,"title":"BioDlink International (1875) Announces Update on Relevant Securities and Takeovers Code Disclosure","media":"Bulletin Express","content":"<p>BioDlink International Company Limited (stock code: 1875) issued an update regarding its relevant securities pursuant to Rule 3.8 of the Hong Kong Code on Takeovers and Mergers. According to the announcement, 142,000 share options vested on 1 March 2026.</p>\n<p>Following this vesting, the company has 772.79 million shares in issue. Among these, 30.02 million are outstanding vested RSA shares for which the full consideration has not yet been received, and 14.56 million remain unvested. In addition, 7.63 million share options remain outstanding, of which 7.35 million are vested but unexercised, and 0.14 million remain unvested.</p>\n<p>The announcement reminds all associates of the company and the offeror—including holders of 5% or more of the relevant securities—to comply with rule-based disclosure obligations during the offer period. It further cautions that completion of the offers is subject to fulfillment or waiver of certain conditions and may therefore not become unconditional.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioDlink International (1875) Announces Update on Relevant Securities and Takeovers Code Disclosure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioDlink International (1875) Announces Update on Relevant Securities and Takeovers Code Disclosure\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-01 18:26</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>BioDlink International Company Limited (stock code: 1875) issued an update regarding its relevant securities pursuant to Rule 3.8 of the Hong Kong Code on Takeovers and Mergers. According to the announcement, 142,000 share options vested on 1 March 2026.</p>\n<p>Following this vesting, the company has 772.79 million shares in issue. Among these, 30.02 million are outstanding vested RSA shares for which the full consideration has not yet been received, and 14.56 million remain unvested. In addition, 7.63 million share options remain outstanding, of which 7.35 million are vested but unexercised, and 0.14 million remain unvested.</p>\n<p>The announcement reminds all associates of the company and the offeror—including holders of 5% or more of the relevant securities—to comply with rule-based disclosure obligations during the offer period. It further cautions that completion of the offers is subject to fulfillment or waiver of certain conditions and may therefore not become unconditional.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01875","symbol_name":"東曜藥業-B","start_time":0,"source_url":"","article_id":"1136110878","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1136110878","pubTimestamp":1772360817,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"BioDlink International Company Limited (stock code: 1875) issued an update regarding its relevant securities pursuant to Rule 3.8 of the Hong Kong Code on Takeovers and Mergers. According to the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01875":"东曜药业-B"},"translate_title":"BioDlink International(1875)宣布更新相关证券及收购守则披露","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01875":1},"content_text":"BioDlink International Company Limited (stock code: 1875) issued an update regarding its relevant securities pursuant to Rule 3.8 of the Hong Kong Code on Takeovers and Mergers. According to the announcement, 142,000 share options vested on 1 March 2026.\nFollowing this vesting, the company has 772.79 million shares in issue. Among these, 30.02 million are outstanding vested RSA shares for which the full consideration has not yet been received, and 14.56 million remain unvested. In addition, 7.63 million share options remain outstanding, of which 7.35 million are vested but unexercised, and 0.14 million remain unvested.\nThe announcement reminds all associates of the company and the offeror—including holders of 5% or more of the relevant securities—to comply with rule-based disclosure obligations during the offer period. It further cautions that completion of the offers is subject to fulfillment or waiver of certain conditions and may therefore not become unconditional.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}